Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yan Liao

Showing results (71-80 of 450) with videos related to

Pageof 45
Sort By:
Oncotarget|June 10, 2015
Elevated preoperative aspartate aminotransferase to lymphocyte ratio index as an independent prognostic factor for patients with hepatocellular carcinoma after hepatic resectionJunfei Jin, Pengpeng Zhu, Yan Liao, et al.
International Journal of Oncology|July 25, 2020
Activation of PGK1 under hypoxic conditions promotes glycolysis and increases stem cell‑like properties and the epithelial‑mesenchymal transition in oral squamous cell carcinoma cells via the AKT signalling pathwayYadong Zhang, Hongshi Cai, Yan Liao, et al.
Chinese Journal of Natural Medicines|July 4, 2020
GL-V9 reverses adriamycin resistance in hepatocellular carcinoma cells by affecting JNK2-related autophagyYue Yang, Yan Liao, Yan-Ping Gui, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|July 24, 2024
Validation of IGA*BSA in Assessing Disease Severity and Response in Patients with Atopic Dermatitis: A Retrospective Cohort Study in ChinaChener Yang, Xia Wu, Jing He, et al.
Cellular & Molecular Biology Letters|October 8, 2024
Caspase-8 in inflammatory diseases: a potential therapeutic targetWangzheqi Zhang, Chenglong Zhu, Yan Liao, et al.
Frontiers in Pharmacology|April 25, 2025
Pan-cancer analysis identified CD248 as a potential target for multiple tumor typesLi Guo, Yan Liao, Xuyang Zhang, et al.
Frontiers in Oncology|June 6, 2019
Prognostic Value of Gamma-Glutamyl Transpeptidase to Lymphocyte Count Ratio in Patients With Single Tumor Size ≤ 5 cm Hepatocellular Carcinoma After Radical ResectionMinjun Liao, Wanying Qin, Yan Liao, et al.
Experimental Cell Research|July 11, 2019
SPIO nanoparticle-labeled bone marrow mesenchymal stem cells inhibit pulmonary EndoMT induced by SiO<sub>2</sub>Rong Jiang, Yan Liao, Fuhuang Yang, et al.
Frontiers in Neuroscience|April 5, 2018
Weighted Synapses Without Carry Operations for RRAM-Based Neuromorphic SystemsYan Liao, Ning Deng, Huaqiang Wu, et al.
Clinical and Experimental Immunology|July 30, 2014
Mesenchymal stem cells suppress CD8+ T cell-mediated activation by suppressing natural killer group 2, member D protein receptor expression and secretion of prostaglandin E2, indoleamine 2, 3-dioxygenase and transforming growth factor-βMingfen Li, Xuyong Sun, Xiaocong Kuang, et al.
Pageof 45

Showing results (71-80 of 450) with videos related to

Sort By:
Pageof 45
Oncotarget|June 10, 2015
Elevated preoperative aspartate aminotransferase to lymphocyte ratio index as an independent prognostic factor for patients with hepatocellular carcinoma after hepatic resectionJunfei Jin, Pengpeng Zhu, Yan Liao, et al.
International Journal of Oncology|July 25, 2020
Activation of PGK1 under hypoxic conditions promotes glycolysis and increases stem cell‑like properties and the epithelial‑mesenchymal transition in oral squamous cell carcinoma cells via the AKT signalling pathwayYadong Zhang, Hongshi Cai, Yan Liao, et al.
Chinese Journal of Natural Medicines|July 4, 2020
GL-V9 reverses adriamycin resistance in hepatocellular carcinoma cells by affecting JNK2-related autophagyYue Yang, Yan Liao, Yan-Ping Gui, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|July 24, 2024
Validation of IGA*BSA in Assessing Disease Severity and Response in Patients with Atopic Dermatitis: A Retrospective Cohort Study in ChinaChener Yang, Xia Wu, Jing He, et al.
Cellular & Molecular Biology Letters|October 8, 2024
Caspase-8 in inflammatory diseases: a potential therapeutic targetWangzheqi Zhang, Chenglong Zhu, Yan Liao, et al.
Frontiers in Pharmacology|April 25, 2025
Pan-cancer analysis identified CD248 as a potential target for multiple tumor typesLi Guo, Yan Liao, Xuyang Zhang, et al.
Frontiers in Oncology|June 6, 2019
Prognostic Value of Gamma-Glutamyl Transpeptidase to Lymphocyte Count Ratio in Patients With Single Tumor Size ≤ 5 cm Hepatocellular Carcinoma After Radical ResectionMinjun Liao, Wanying Qin, Yan Liao, et al.
Experimental Cell Research|July 11, 2019
SPIO nanoparticle-labeled bone marrow mesenchymal stem cells inhibit pulmonary EndoMT induced by SiO<sub>2</sub>Rong Jiang, Yan Liao, Fuhuang Yang, et al.
Frontiers in Neuroscience|April 5, 2018
Weighted Synapses Without Carry Operations for RRAM-Based Neuromorphic SystemsYan Liao, Ning Deng, Huaqiang Wu, et al.
Clinical and Experimental Immunology|July 30, 2014
Mesenchymal stem cells suppress CD8+ T cell-mediated activation by suppressing natural killer group 2, member D protein receptor expression and secretion of prostaglandin E2, indoleamine 2, 3-dioxygenase and transforming growth factor-βMingfen Li, Xuyong Sun, Xiaocong Kuang, et al.
Pageof 45